{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:59:38Z","timestamp":1787313578082,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Intramural Research Program of NIH, The National Institute of Diabetes and Digestive and Kidney Diseases"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims\/hypothesis<\/jats:title>\n                    <jats:p>\n                      An R1420H variation in sulfonylurea receptor 1 (SUR1), a subunit of the K\n                      <jats:sub>ATP<\/jats:sub>\n                      channel, was previously identified in an Indigenous community in Arizona where a homozygous carrier (1420HH) had hyperinsulinaemic hypoglycaemia during infancy (HHI), suggestive of a K\n                      <jats:sub>ATP<\/jats:sub>\n                      channel loss of function (LoF). Interestingly, heterozygous carriers of this variation (1420RH, occurring in 3% of the community), had a twofold increased risk of type 2 diabetes. We aimed to create an isogenic induced pluripotent stem cell (iPSC)-derived pancreatic islet (SC-islet)-based platform to test whether the R1420H variant results in K\n                      <jats:sub>ATP<\/jats:sub>\n                      channel LoF, and to examine the distinct temporal effects of SUR1 1420HH and 1420RH K\n                      <jats:sub>ATP<\/jats:sub>\n                      channel variations on insulin secretion from developing and mature SC-islets.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using CRISPR-Cas9, isogenic iPSCs with all three genotypes (SUR1 1420RR, 1420RH and 1420HH) were generated from two different parental Indigenous American iPSC lines (IS1, isogenic cell lines derived from parental cell line 1; and IS2, isogenic cell lines derived from parental cell line 2). These isogenic cell lines were used to generate immature SC-islets (resembling fetal islets) and mature SC-islets (resembling adult islets), which were used to assess insulin secretion dynamics during different stages of development and identify differences in gene expression by single-cell RNA-seq. This study was consistent with the CONSIDER statement for research studies among Indigenous American communities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Immature SUR1 1420HH SC-islets secreted 3.4-fold (IS1,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001) and 4.2-fold (IS2,\n                      <jats:italic>p<\/jats:italic>\n                      =0.001) more insulin under basal conditions than normal (SUR1 1420RR) SC-islets. Modest hyperinsulinaemia was also seen in immature SUR1 1420RH SC-islets (2.2-fold [IS1] and 2.3-fold [IS2]) but the results were not statistically significant. After maturation, the 1420HH SC-islets failed to achieve glucose responsiveness whereas the 1420RH SC-islets achieved biphasic insulin secretion but had significantly lower glucose responsiveness than normal SC-islets (AUC for insulin secretion [as a % of total insulin] under high glucose challenge: 1.04 vs 0.56 in normal vs 1420RH SC-islets,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001). Diazoxide reduced hyperinsulinaemia in SUR1 1420RH and 1420HH immature SC-islets, while tolbutamide elicited a greatly diminished or undetectable insulin secretory response from mature SUR1 1420RH SC-islets (13.2-fold increase in insulin secretion) and 1420HH SC-islets (1.9-fold increase) compared with normal SC-islets (31.5-fold increase). Results were directionally comparable for both IS1 and IS2 SC-islets. SUR1 1420RH SC-islets also responded to the glucokinase activator dorzagliatin with improvement in first-phase insulin secretory response (first-phase stimulation index: 3.9-fold vs 7.3-fold,\n                      <jats:italic>p<\/jats:italic>\n                      =0.01 [IS1, 11 mmol\/l glucose \u00b1 dorzagliatin]; 5.5-fold vs 9.0-fold,\n                      <jats:italic>p<\/jats:italic>\n                      =0.13 [IS1, 20 mmol\/l glucose \u00b1 dorzagliatin]). Single-cell RNA-seq identified dysregulated genes in SUR1 1420RH SC-beta cells, including lower expression of glycolytic genes and upregulation of\n                      <jats:italic>G6PC2<\/jats:italic>\n                      , which could explain the lower insulin secretory response to glucose.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\/interpretation<\/jats:title>\n                    <jats:p>\n                      A SUR1 R1420H variant identified in an Indigenous American population causes hyperinsulinaemia in homozygous immature SC-islets during basal conditions and these SC-islets fail to achieve glucose responsiveness after maturation. In the heterozygous state, modest hyperinsulinaemia is observed in immature SC-islets, which after maturation have significantly lower glucose responsiveness. These results demonstrate that SUR1 R1420H is a K\n                      <jats:sub>ATP<\/jats:sub>\n                      channel LoF variation and suggest that a lower insulin secretory response during adulthood is the cause of the higher type 2 diabetes risk in individuals heterozygous for this variation. We also show that the isogenic iPSC-based platform can be used to test therapeutic agents to treat HHI in infants homozygous for LoF K\n                      <jats:sub>ATP<\/jats:sub>\n                      channels and screen for drugs that can improve glucose-responsive insulin secretion in adult heterozygous carriers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data availability<\/jats:title>\n                    <jats:p>\n                      See the database of Genotypes and Phenotypes (dbGaP; dbgap.ncbi.nlm.nih.gov\/home; accession no.: phs002490.v1.p1) for details concerning data requests. All source codes can be found in the GitHub repository under\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/github.com\/Koushik-Cheranda\/SC-islet-scRNAseq-analysis-R-codes\" ext-link-type=\"uri\">https:\/\/github.com\/Koushik-Cheranda\/SC-islet-scRNAseq-analysis-R-codes<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00125-025-06605-1","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:47:04Z","timestamp":1764103624000},"page":"399-420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Modelling the effects of human SUR1 R1420H variation on insulin secretory function using isogenic iPSC-derived pancreatic islets"],"prefix":"10.1007","volume":"69","author":[{"given":"Anup K.","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katiya","family":"Barkho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushik Ponnanna","family":"Cheranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Traurig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Anup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton","family":"Bogardus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie J.","family":"Baier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"1","key":"6605_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13059-023-02935-8","volume":"24","author":"S Gersing","year":"2023","unstructured":"Gersing S, Cagiada M, Gebbia M et al (2023) A comprehensive map of human glucokinase variant activity. Genome Biol 24(1):97. https:\/\/doi.org\/10.1186\/s13059-023-02935-8","journal-title":"Genome Biol"},{"issue":"12","key":"6605_CR2","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1007\/s00125-021-05553-w","volume":"64","author":"S Langer","year":"2021","unstructured":"Langer S, Waterstradt R, Hillebrand G, Santer R, Baltrusch S (2021) The novel variant GCK p.Val455Leu associated with hyperinsulinism is susceptible to allosteric activation and is conducive to weight gain and the development of diabetes. Diabetologia 64(12):2687\u20132700. https:\/\/doi.org\/10.1007\/s00125-021-05553-w","journal-title":"Diabetologia"},{"issue":"11","key":"6605_CR3","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/humu.21110","volume":"30","author":"KK Osbak","year":"2009","unstructured":"Osbak KK, Colclough K, Saint-Martin C et al (2009) Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 30(11):1512\u20131526. https:\/\/doi.org\/10.1002\/humu.21110","journal-title":"Hum Mutat"},{"issue":"5993","key":"6605_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/312446a0","volume":"312","author":"FM Ashcroft","year":"1984","unstructured":"Ashcroft FM, Harrison DE, Ashcroft SJH (1984) Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 312(5993):446\u2013448. https:\/\/doi.org\/10.1038\/312446a0","journal-title":"Nature"},{"issue":"4","key":"6605_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1530\/Eje-12-0673","volume":"168","author":"RR Kapoor","year":"2013","unstructured":"Kapoor RR, Flanagan SE, Arya VB, Shield JP, Ellard S, Hussain K (2013) Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol 168(4):557\u2013564. https:\/\/doi.org\/10.1530\/Eje-12-0673","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"6605_CR6","doi-asserted-by":"publisher","first-page":"E355","DOI":"10.1210\/jc.2012-2169","volume":"98","author":"KE Snider","year":"2013","unstructured":"Snider KE, Becker S, Boyajian L et al (2013) Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocr Metab 98(2):E355\u2013E363. https:\/\/doi.org\/10.1210\/jc.2012-2169","journal-title":"J Clin Endocr Metab"},{"issue":"1","key":"6605_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1152\/physrev.00022.2003","volume":"84","author":"MJ Dunne","year":"2004","unstructured":"Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A, Lindley KJ (2004) Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev 84(1):239\u2013275. https:\/\/doi.org\/10.1152\/physrev.00022.2003","journal-title":"Physiol Rev"},{"issue":"11","key":"6605_CR8","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2337\/diab.46.11.1743","volume":"46","author":"A Nestorowicz","year":"1997","unstructured":"Nestorowicz A, Inagaki N, Gonoi T et al (1997) A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 46(11):1743\u20131748. https:\/\/doi.org\/10.2337\/diab.46.11.1743","journal-title":"Diabetes"},{"issue":"5209","key":"6605_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1126\/science.7716548","volume":"268","author":"PM Thomas","year":"1995","unstructured":"Thomas PM, Cote GJ, Wohllk N et al (1995) Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268(5209):426\u2013429. https:\/\/doi.org\/10.1126\/science.7716548","journal-title":"Science"},{"issue":"11","key":"6605_CR10","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.2337\/db12-1611","volume":"62","author":"K Shimomura","year":"2013","unstructured":"Shimomura K, Tusa M, Iberl M et al (2013) A mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1. Diabetes 62(11):3797\u20133806. https:\/\/doi.org\/10.2337\/db12-1611","journal-title":"Diabetes"},{"issue":"12","key":"6605_CR11","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.2337\/db15-0459","volume":"64","author":"LJ Baier","year":"2015","unstructured":"Baier LJ, Muller YL, Remedi MS et al (2015) ABCC8 R1420H loss-of-function variant in a southwest American Indian community: association with increased birth weight and doubled risk of type 2 diabetes. Diabetes 64(12):4322\u20134332. https:\/\/doi.org\/10.2337\/db15-0459","journal-title":"Diabetes"},{"issue":"2","key":"6605_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2337\/diabetes.48.2.408","volume":"48","author":"T Otonkoski","year":"1999","unstructured":"Otonkoski T, Amm\u00e4l\u00e4 C, Huopio H et al (1999) A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes 48(2):408\u2013415. https:\/\/doi.org\/10.2337\/diabetes.48.2.408","journal-title":"Diabetes"},{"issue":"3","key":"6605_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00125-020-05346-7","volume":"64","author":"V Lithovius","year":"2021","unstructured":"Lithovius V, Saarim\u00e4ki-Vire J, Balboa D et al (2021) SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism. Diabetologia 64(3):630\u2013640. https:\/\/doi.org\/10.1007\/s00125-020-05346-7","journal-title":"Diabetologia"},{"issue":"7","key":"6605_CR14","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41587-022-01219-z","volume":"40","author":"D Balboa","year":"2022","unstructured":"Balboa D, Barsby T, Lithovius V et al (2022) Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nat Biotechnol 40(7):1042\u20131055. https:\/\/doi.org\/10.1038\/s41587-022-01219-z","journal-title":"Nat Biotechnol"},{"issue":"2","key":"6605_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.stemcr.2018.12.012","volume":"12","author":"L Velazco-Cruz","year":"2019","unstructured":"Velazco-Cruz L, Song J, Maxwell KG et al (2019) Acquisition of dynamic function in human stem cell-derived \u03b2 cells. Stem Cell Reports 12(2):351\u2013365. https:\/\/doi.org\/10.1016\/j.stemcr.2018.12.012","journal-title":"Stem Cell Reports"},{"key":"6605_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12874-019-0815-8","volume":"19","author":"T Huria","year":"2019","unstructured":"Huria T, Palmer SC, Pitama S et al (2019) Consolidated criteria for strengthening reporting of health research involving indigenous peoples: the CONSIDER statement. BMC Med Res Methodol 19:173. https:\/\/doi.org\/10.1186\/s12874-019-0815-8","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"6605_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nbt.3033","volume":"32","author":"A Rezania","year":"2014","unstructured":"Rezania A, Bruin JE, Arora P et al (2014) Reversal of diabetes with insulin-producing cells derived from human pluripotent stem cells. Nat Biotechnol 32(11):1121\u20131133. https:\/\/doi.org\/10.1038\/nbt.3033","journal-title":"Nat Biotechnol"},{"issue":"4","key":"6605_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41587-020-0430-6","volume":"38","author":"NJ Hogrebe","year":"2020","unstructured":"Hogrebe NJ, Augsornworawat P, Maxwell KG, Velazco-Cruz L, Millman JR (2020) Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells. Nat Biotechnol 38(4):460\u2013470. https:\/\/doi.org\/10.1038\/s41587-020-0430-6","journal-title":"Nat Biotechnol"},{"issue":"7756","key":"6605_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41586-019-1168-5","volume":"569","author":"A Veres","year":"2019","unstructured":"Veres A, Faust AL, Bushnell HL et al (2019) Charting cellular identity during human in vitro beta-cell differentiation. Nature 569(7756):368\u2013373. https:\/\/doi.org\/10.1038\/s41586-019-1168-5","journal-title":"Nature"},{"issue":"1","key":"6605_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/db17-0120","volume":"67","author":"L Sui","year":"2018","unstructured":"Sui L, Danzl N, Campbell SR et al (2018) Beta-cell replacement in mice using human type 1 diabetes nuclear transfer embryonic stem cells. Diabetes 67(1):26\u201335. https:\/\/doi.org\/10.2337\/db17-0120","journal-title":"Diabetes"},{"issue":"4","key":"6605_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"6605_CR22","doi-asserted-by":"publisher","unstructured":"Nair AK, Traurig M, Sutherland JR et al (2022) Generation of isogenic hiPSCs with targeted edits at multiple intronic SNPs to study the effects of the type 2 diabetes associated KCNQ1 locus in American Indians. Cells-Basel 11(9):1446. https:\/\/doi.org\/10.3390\/cells11091446","DOI":"10.3390\/cells11091446"},{"issue":"1","key":"6605_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13059-019-1662-y","volume":"20","author":"ATL Lun","year":"2019","unstructured":"Lun ATL, Riesenfeld S, Andrews T et al (2019) EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data. Genome Biol 20(1):63. https:\/\/doi.org\/10.1186\/s13059-019-1662-y","journal-title":"Genome Biol"},{"issue":"13","key":"6605_CR24","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E et al (2021) Integrated analysis of multimodal single-cell data. Cell 184(13):3573-3587 e3529. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048","journal-title":"Cell"},{"issue":"12","key":"6605_CR25","doi-asserted-by":"publisher","first-page":"giaa151","DOI":"10.1093\/gigascience\/giaa151","volume":"9","author":"MD Young","year":"2020","unstructured":"Young MD, Behjati S (2020) SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. Gigascience 9(12):giaa151. https:\/\/doi.org\/10.1093\/gigascience\/giaa151","journal-title":"Gigascience"},{"issue":"4","key":"6605_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis CS, Murrow LM, Gartner ZJ (2019) DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst 8(4):329-337 e324. https:\/\/doi.org\/10.1016\/j.cels.2019.03.003","journal-title":"Cell Syst"},{"issue":"1","key":"6605_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister C, Satija R (2019) Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol 20(1):296. https:\/\/doi.org\/10.1186\/s13059-019-1874-1","journal-title":"Genome Biol"},{"key":"6605_CR28","doi-asserted-by":"publisher","unstructured":"Marsh SE (2021) scCustomize: custom visualizations & functions for streamlined analyses of single cell sequencing. Available from: https:\/\/doi.org\/10.5281\/zenodo.5706430. Accessed: 12 Feb 2024","DOI":"10.5281\/zenodo.5706430"},{"issue":"8","key":"6605_CR29","doi-asserted-by":"publisher","first-page":"111238","DOI":"10.1016\/j.celrep.2022.111238","volume":"40","author":"N Cuesta-Gomez","year":"2022","unstructured":"Cuesta-Gomez N, Verhoeff K, Jasra IT, Pawlick R, Dadheech N, Shapiro AMJ (2022) Characterization of stem-cell-derived islets during differentiation and after implantation. Cell Rep 40(8):111238. https:\/\/doi.org\/10.1016\/j.celrep.2022.111238","journal-title":"Cell Rep"},{"issue":"8","key":"6605_CR30","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.2337\/db12-1767","volume":"62","author":"RL Hanson","year":"2013","unstructured":"Hanson RL, Guo T, Muller YL et al (2013) Strong parent-of-origin effects in the association of KCNQ1 variants with type 2 diabetes in American Indians. Diabetes 62(8):2984\u20132991. https:\/\/doi.org\/10.2337\/db12-1767","journal-title":"Diabetes"},{"issue":"27","key":"6605_CR31","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.1073\/pnas.1422104112","volume":"112","author":"S Asahara","year":"2015","unstructured":"Asahara S, Etoh H, Inoue H et al (2015) Paternal allelic mutation at the locus reduces pancreatic \u03b2-cell mass by epigenetic modification of cdkn1c. P Natl Acad Sci USA 112(27):8332\u20138337. https:\/\/doi.org\/10.1073\/pnas.1422104112","journal-title":"P Natl Acad Sci USA"},{"key":"6605_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fphys.2019.00148","volume":"10","author":"FM Matschinsky","year":"2019","unstructured":"Matschinsky FM, Wilson DF (2019) The central role of glucokinase in glucose homeostasis: a perspective 50 years after demonstrating the presence of the enzyme in islets of Langerhans. Front Physiol 10:148. https:\/\/doi.org\/10.3389\/fphys.2019.00148","journal-title":"Front Physiol"},{"issue":"1","key":"6605_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12864-024-10013-x","volume":"25","author":"MD Schmidt","year":"2024","unstructured":"Schmidt MD, Ishahak M, Augsornworawat P, Millman JR (2024) Comparative and integrative single cell analysis reveals new insights into the transcriptional immaturity of stem cell-derived \u03b2 cells. BMC Genomics 25(1):105. https:\/\/doi.org\/10.1186\/s12864-024-10013-x","journal-title":"BMC Genomics"},{"issue":"1","key":"6605_CR34","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/1471-2164-15-620","volume":"15","author":"C Benner","year":"2014","unstructured":"Benner C, van der Meulen T, Cac\u00e9res E, Tigyi K, Donaldson CJ, Huising MO (2014) The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics 15(1):620. https:\/\/doi.org\/10.1186\/1471-2164-15-620","journal-title":"BMC Genomics"},{"issue":"7","key":"6605_CR35","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2337\/db17-0029","volume":"66","author":"C Li","year":"2017","unstructured":"Li C, Ackermann AM, Boodhansingh KE et al (2017) Functional and metabolomic consequences of KATP channel inactivation in human islets. Diabetes 66(7):1901\u20131913. https:\/\/doi.org\/10.2337\/db17-0029","journal-title":"Diabetes"},{"issue":"9","key":"6605_CR36","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.2337\/db14-1202","volume":"64","author":"RJ Salisbury","year":"2015","unstructured":"Salisbury RJ, Han B, Jennings RE et al (2015) Altered phenotype of \u03b2-cells and other pancreatic cell lineages in patients with diffuse congenital hyperinsulinism in infancy caused by mutations in the ATP-sensitive K-channel. Diabetes 64(9):3182\u20133188. https:\/\/doi.org\/10.2337\/db14-1202","journal-title":"Diabetes"},{"issue":"4","key":"6605_CR37","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/bf00283651","volume":"26","author":"J Rahier","year":"1984","unstructured":"Rahier J, Falt K, Muntefering H, Becker K, Gepts W, Falkmer S (1984) The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia 26(4):282\u2013289. https:\/\/doi.org\/10.1007\/bf00283651","journal-title":"Diabetologia"},{"issue":"7","key":"6605_CR38","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2337\/diabetes.47.7.1145","volume":"47","author":"SL Shyng","year":"1998","unstructured":"Shyng SL, Ferrigni T, Shepard JB, Nestorowicz A, Glaser B, Permutt MA, Nichols CG (1998) Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy. Diabetes 47(7):1145\u20131151. https:\/\/doi.org\/10.2337\/diabetes.47.7.1145","journal-title":"Diabetes"},{"issue":"12","key":"6605_CR39","doi-asserted-by":"publisher","first-page":"11096","DOI":"10.1074\/jbc.m312810200","volume":"279","author":"F Yan","year":"2004","unstructured":"Yan F, Lin CW, Weisiger E, Cartier EA, Taschenberger G, Shyng SL (2004) Sulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptor. J Biol Chem 279(12):11096\u201311105. https:\/\/doi.org\/10.1074\/jbc.m312810200","journal-title":"J Biol Chem"},{"issue":"1","key":"6605_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2337\/diabetes.49.1.114","volume":"49","author":"Y Tanizawa","year":"2000","unstructured":"Tanizawa Y, Matsuda K, Matsuo M et al (2000) Genetic analysis of Japanese patients with persistent hyperinsulinemic hypoglycemia of infancy: nucleotide-binding fold-2 mutation impairs cooperative binding of adenine nucleotides to sulfonylurea receptor 1. Diabetes 49(1):114\u2013120. https:\/\/doi.org\/10.2337\/diabetes.49.1.114","journal-title":"Diabetes"},{"issue":"52","key":"6605_CR41","doi-asserted-by":"publisher","first-page":"41184","DOI":"10.1074\/jbc.m006503200","volume":"275","author":"M Matsuo","year":"2000","unstructured":"Matsuo M, Trapp S, Tanizawa Y et al (2000) Functional analysis of a mutant sulfonylurea receptor, SUR1-R1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancy. J Biol Chem 275(52):41184\u201341191. https:\/\/doi.org\/10.1074\/jbc.m006503200","journal-title":"J Biol Chem"},{"issue":"8016","key":"6605_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J et al (2024) Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630(8016):493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w","journal-title":"Nature"},{"issue":"D1","key":"6605_CR43","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim S, Chen J, Cheng T et al (2025) PubChem 2025 update. Nucleic Acids Res 53(D1):D1516\u2013D1525. https:\/\/doi.org\/10.1093\/nar\/gkae1059","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"6605_CR44","doi-asserted-by":"publisher","first-page":"W324","DOI":"10.1093\/nar\/gkae300","volume":"52","author":"M Bugnon","year":"2024","unstructured":"Bugnon M, Rohrig UF, Goullieux M et al (2024) SwissDock 2024: major enhancements for small-molecule docking with attracting cavities and AutoDock Vina. Nucleic Acids Res 52(W1):W324\u2013W332. https:\/\/doi.org\/10.1093\/nar\/gkae300","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"6605_CR45","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46(W1):W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"6605_CR46","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1073\/pnas.89.13.5744","volume":"89","author":"M Tal","year":"1992","unstructured":"Tal M, Wu YJ, Leiser M et al (1992) [Val12] HRAS downregulates GLUT2 in beta cells of transgenic mice without affecting glucose homeostasis. Proc Natl Acad Sci U S A 89(13):5744\u20135748. https:\/\/doi.org\/10.1073\/pnas.89.13.5744","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"6605_CR47","doi-asserted-by":"publisher","first-page":"dmm033316","DOI":"10.1242\/dmm.033316","volume":"11","author":"B Lu","year":"2018","unstructured":"Lu B, Kurmi K, Munoz-Gomez M et al (2018) Impaired \u03b2-cell glucokinase as an underlying mechanism in diet-induced diabetes. Dis Model Mech 11(6):dmm033316. https:\/\/doi.org\/10.1242\/dmm.033316","journal-title":"Dis Model Mech"},{"issue":"9","key":"6605_CR48","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1073\/pnas.94.9.4372","volume":"94","author":"HY Wang","year":"1997","unstructured":"Wang HY, Iynedjian PB (1997) Modulation of glucose responsiveness of insulinoma beta-cells by graded overexpression of glucokinase. P Natl Acad Sci USA 94(9):4372\u20134377. https:\/\/doi.org\/10.1073\/pnas.94.9.4372","journal-title":"P Natl Acad Sci USA"},{"issue":"41","key":"6605_CR49","doi-asserted-by":"publisher","first-page":"25731","DOI":"10.1074\/jbc.272.41.25731","volume":"272","author":"H Wang","year":"1997","unstructured":"Wang H, Iynedjian PB (1997) Acute glucose intolerance in insulinoma cells with unbalanced overexpression of glucokinase. J Biol Chem 272(41):25731\u201325736. https:\/\/doi.org\/10.1074\/jbc.272.41.25731","journal-title":"J Biol Chem"},{"issue":"6","key":"6605_CR50","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1073\/pnas.91.6.2051","volume":"91","author":"S Efrat","year":"1994","unstructured":"Efrat S, Leiser M, Wu YJ et al (1994) Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. Proc Natl Acad Sci U S A 91(6):2051\u20132055. https:\/\/doi.org\/10.1073\/pnas.91.6.2051","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"6605_CR51","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2337\/db12-1067","volume":"62","author":"LD Pound","year":"2013","unstructured":"Pound LD, Oeser JK, O\u2019Brien TP et al (2013) G6PC2: a negative regulator of basal glucose-stimulated insulin secretion. Diabetes 62(5):1547\u20131556. https:\/\/doi.org\/10.2337\/db12-1067","journal-title":"Diabetes"},{"issue":"4","key":"6605_CR52","doi-asserted-by":"publisher","first-page":"101729","DOI":"10.1016\/j.jbc.2022.101729","volume":"298","author":"M Rahim","year":"2022","unstructured":"Rahim M, Nakhe AY, Banerjee DR et al (2022) Glucose-6-phosphatase catalytic subunit 2 negatively regulates glucose oxidation and insulin secretion in pancreatic beta-cells. J Biol Chem 298(4):101729. https:\/\/doi.org\/10.1016\/j.jbc.2022.101729","journal-title":"J Biol Chem"},{"issue":"5","key":"6605_CR53","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41591-022-01802-6","volume":"28","author":"DL Zhu","year":"2022","unstructured":"Zhu DL, Li XY, Ma JH et al (2022) Dorzagliatin in drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med 28(5):965\u2013973. https:\/\/doi.org\/10.1038\/s41591-022-01802-6","journal-title":"Nat Med"},{"issue":"2","key":"6605_CR54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2337\/db22-0708","volume":"72","author":"E Chow","year":"2023","unstructured":"Chow E, Wang K, Lim CKP et al (2023) Dorzagliatin, a dual-acting glucokinase activator, increases insulin secretion and glucose sensitivity in glucokinase maturity-onset diabetes of the young and recent-onset type 2 diabetes. Diabetes 72(2):299\u2013308. https:\/\/doi.org\/10.2337\/db22-0708","journal-title":"Diabetes"},{"issue":"5","key":"6605_CR55","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cmet.2020.10.007","volume":"32","author":"SL Lewandowski","year":"2020","unstructured":"Lewandowski SL, Cardone RL, Foster HR et al (2020) Pyruvate kinase controls signal strength in the insulin secretory pathway. Cell Metab 32(5):736-750.e5. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.007","journal-title":"Cell Metab"},{"issue":"7","key":"6605_CR56","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2022.06.003","volume":"34","author":"MJ Merrins","year":"2022","unstructured":"Merrins MJ, Corkey BE, Kibbey RG, Prentki M (2022) Metabolic cycles and signals for insulin secretion. Cell Metab 34(7):947\u2013968. https:\/\/doi.org\/10.1016\/j.cmet.2022.06.003","journal-title":"Cell Metab"},{"issue":"10","key":"6605_CR57","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.2337\/db11-0083","volume":"60","author":"MC Akerfeldt","year":"2011","unstructured":"Akerfeldt MC, Laybutt DR (2011) Inhibition of Id1 augments insulin secretion and protects against high-fat diet-induced glucose intolerance. Diabetes 60(10):2506\u20132514. https:\/\/doi.org\/10.2337\/db11-0083","journal-title":"Diabetes"},{"issue":"2","key":"6605_CR58","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1073\/pnas.0913610107","volume":"107","author":"MO Huising","year":"2010","unstructured":"Huising MO, van der Meulen T, Vaughan JM et al (2010) CRFR1 is expressed on pancreatic \u03b2 cells, promotes \u03b2 cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. P Natl Acad Sci USA 107(2):912\u2013917. https:\/\/doi.org\/10.1073\/pnas.0913610107","journal-title":"P Natl Acad Sci USA"},{"issue":"8","key":"6605_CR59","doi-asserted-by":"publisher","first-page":"108067","DOI":"10.1016\/j.celrep.2021.108850","volume":"32","author":"P Augsornworawat","year":"2020","unstructured":"Augsornworawat P, Maxwell KG, Velazco-Cruz L, Millman JR (2020) Single-cell transcriptome profiling reveals \u03b2 cell maturation in stem cell-derived islets after transplantation. Cell Rep 32(8):108067. https:\/\/doi.org\/10.1016\/j.celrep.2021.108850","journal-title":"Cell Rep"},{"issue":"8","key":"6605_CR60","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.2337\/db14-1752","volume":"64","author":"HS Spijker","year":"2015","unstructured":"Spijker HS, Song H, Ellenbroek JH et al (2015) Loss of \u03b2-cell identity occurs in type 2 diabetes and is associated with islet amyloid deposits. Diabetes 64(8):2928\u20132938. https:\/\/doi.org\/10.2337\/db14-1752","journal-title":"Diabetes"},{"issue":"11","key":"6605_CR61","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.2337\/dc13-0705","volume":"36","author":"MG White","year":"2013","unstructured":"White MG, Marshall HL, Rigby R et al (2013) Expression of mesenchymal and \u03b1 -cell phenotypic markers in islet \u03b2 -cells in recently diagnosed diabetes. Diabetes Care 36(11):3818\u20133820. https:\/\/doi.org\/10.2337\/dc13-0705","journal-title":"Diabetes Care"},{"issue":"8","key":"6605_CR62","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.cmet.2021.05.015","volume":"33","author":"XM Tang","year":"2021","unstructured":"Tang XM, Uhl S, Zhang T et al (2021) SARS-CoV-2 infection induces beta cell transdifferentiation. Cell Metab 33(8):1577-1591.e7. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.015","journal-title":"Cell Metab"},{"issue":"1","key":"6605_CR63","doi-asserted-by":"publisher","first-page":"e143791","DOI":"10.1172\/jci.insight.143791","volume":"6","author":"K Amo-Shiinoki","year":"2021","unstructured":"Amo-Shiinoki K, Tanabe K, Hoshii Y et al (2021) Islet cell dedifferentiation is a pathologic mechanism of long-standing progression of type 2 diabetes. JCI Insight 6(1):e143791. https:\/\/doi.org\/10.1172\/jci.insight.143791","journal-title":"JCI Insight"},{"issue":"1","key":"6605_CR64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1210\/jc.2018-00968","volume":"104","author":"JJ Sun","year":"2019","unstructured":"Sun JJ, Ni QC, Xie J et al (2019) \u03b2-cell dedifferentiation in patients with T2D with adequate glucose control and nondiabetic chronic pancreatitis. J Clin Endocr Metab 104(1):83\u201394. https:\/\/doi.org\/10.1210\/jc.2018-00968","journal-title":"J Clin Endocr Metab"},{"issue":"3","key":"6605_CR65","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1210\/jc.2015-2860","volume":"101","author":"F Cinti","year":"2016","unstructured":"Cinti F, Bouchi R, Kim-Muller JY et al (2016) Evidence of \u03b2-cell dedifferentiation in human type 2 diabetes. J Clin Endocr Metab 101(3):1044\u20131054. https:\/\/doi.org\/10.1210\/jc.2015-2860","journal-title":"J Clin Endocr Metab"},{"key":"6605_CR66","doi-asserted-by":"publisher","first-page":"12631","DOI":"10.1038\/ncomms12631","volume":"7","author":"JY Kim-Muller","year":"2016","unstructured":"Kim-Muller JY, Fan J, Kim YJ et al (2016) Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic beta cells in diabetic mice. Nat Commun 7:12631. https:\/\/doi.org\/10.1038\/ncomms12631","journal-title":"Nat Commun"},{"issue":"8","key":"6605_CR67","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.2337\/db16-1355","volume":"66","author":"JS Stancill","year":"2017","unstructured":"Stancill JS, Cartailler JP, Clayton HW et al (2017) Chronic \u03b2-cell depolarization impairs \u03b2-cell identity by disrupting a network of Ca2+-regulated genes. Diabetes 66(8):2175\u20132187. https:\/\/doi.org\/10.2337\/db16-1355","journal-title":"Diabetes"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06605-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:02:01Z","timestamp":1767823321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06605-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["6605"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06605-1","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We thank the volunteers who provided blood cells for the generation of iPSCs and consented to this study. This work used the computational resources of the NIH HPC Biowulf cluster.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"Further information about resources and reagents should be directed to the corresponding author. There are restrictions to the availability of human iPSCs lines used and generated in this study because these cell lines were generated from blood cells from Indigenous American individuals. The Indigenous community has not consented to the sharing of biospecimens with outside researchers and collaborators. All other reagents are available on reasonable request. Single-cell sequencing data reported in this study cannot be deposited in a public repository because data were generated from Indigenous American iPSCs. Inquiries about these data can be made to the corresponding author. See the database of Genotypes and Phenotypes (dbGaP; dbgap.ncbi.nlm.nih.gov\/home; accession no.: phs002490.v1.p1) for details concerning data requests. All source codes can be found in the GitHub repository under\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Open access funding provided by the National Institutes of Health. This research was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH). The contributions of the NIH author(s) are considered Works of the United States Government. The findings and conclusions presented in this paper are those of the author(s) and do not necessarily reflect the views of the NIH or the US Department of Health and Human Services. The study sponsor\/funder was not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; and did not impose any restrictions regarding the publication of the report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"AKN contributed to study design, performed stem cell culture, generation of isogenic cell lines, and differentiations, and data analysis and wrote the first version of the manuscript. KB assisted with the characterisation of stem cell lines, data acquisition, and edited the manuscript. KPC performed the bioinformatic analysis of single-cell data and in silico modelling, and assisted with data analysis and writing the manuscript. MT assisted with the characterisation of stem cell lines, generated single-cell libraries and edited the manuscript. JRS assisted with data acquisition and edited the manuscript. DA assisted with data acquisition and data analysis, and edited the manuscript. CB contributed to the study design and edited the manuscript. LJB contributed to the study design, and revised and edited the manuscript. All authors approved the final version of the manuscript. LJB is the guarantor of the work as a whole and accepts full responsibility for the work and\/or the conduct of the study, had access to the data, and controlled the decision to publish.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}